Stefan Franzen

AstraZeneca R&D
Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 183 publications

Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study.

Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study.

Journal: Advances in therapy

Published: March 26, 2026

Excess risk of cardiovascular disease and mortality after amputation in type 2 diabetes: a nationwide population study from the Swedish National Diabetes Register.

Excess risk of cardiovascular disease and mortality after amputation in type 2 diabetes: a nationwide population study from the Swedish National Diabetes Register.

Journal: Cardiovascular diabetology

Published: February 14, 2026

Occurrence and Patient Characteristics of Aldosterone Dysregulation in Routine Clinical Care: A Population-Based Study.

Occurrence and Patient Characteristics of Aldosterone Dysregulation in Routine Clinical Care: A Population-Based Study.

Journal: JACC. Advances

Published: September 15, 2025

Correction to: Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Correction to: Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Journal: Kidney360

Published: August 26, 2025

Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study.

Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study.

Journal: Journal of the American College of Cardiology

Published: August 22, 2025

Filling the Gaps in Health Data: Using a Machine Learning Approach to Augment Partially Observed Variables Such as Smoking in Claims Data.

Filling the Gaps in Health Data: Using a Machine Learning Approach to Augment Partially Observed Variables Such as Smoking in Claims Data.

Journal: Pharmacoepidemiology and drug safety

Published: July 04, 2025

Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data.

Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data.

Journal: Pharmacoepidemiology and drug safety

Published: April 30, 2025

The mechanism of autoreduction in Dehaloperoxidase-A.

The mechanism of autoreduction in Dehaloperoxidase-A.

Journal: Biochemical and biophysical research communications

Published: October 15, 2024

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode.

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode.

Journal: ESC heart failure

Published: September 06, 2024

Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality.

Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 13, 2024

Structural Comparison of Substrate Binding Sites in Dehaloperoxidase A and B.

Structural Comparison of Substrate Binding Sites in Dehaloperoxidase A and B.

Journal: Biochemistry

Published: July 03, 2024

The role of proton-coupled electron transfer from protein to heme in dehaloperoxidase.

The role of proton-coupled electron transfer from protein to heme in dehaloperoxidase.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: May 30, 2024

Showing 1-12 of 183

Last Updated: 09/26/2026